These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21376690)

  • 41. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
    Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
    Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
    Cheng FW; Lee V; To KF; Chan KC; Shing MK; Li CK
    Pediatr Blood Cancer; 2009 Dec; 53(7):1329-31. PubMed ID: 19591223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.
    Mamzer-Bruneel MF; Lomé C; Morelon E; Levy V; Bourquelot P; Jacobs F; Gessain A; Mac Intyre E; Brousse N; Kreis H; Hermine O
    J Clin Oncol; 2000 Nov; 18(21):3622-32. PubMed ID: 11054435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-CD20 monoclonal antibody treatment of Epstein-Barr virus-induced intrahepatic lymphoproliferative disorder following liver transplantation.
    Yedibela S; Reck T; Niedobitek G; Gramatzki M; Repp R; Hohenberger W; Ott R
    Transpl Int; 2003 Mar; 16(3):197-201. PubMed ID: 12664216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delayed and overlooked diagnosis of an unusual opportunistic infection in a renal transplant recipient: visceral leishmaniasis.
    Zümrütdal A; Erken E; Turunç T; Çolakoğlu Ş; Demıroğlu YZ; Özelsancak R; Solmaz S
    Turkiye Parazitol Derg; 2010; 34(4):183-5. PubMed ID: 21391189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders.
    Boratyńska M; Smolska D
    Transpl Int; 2008 Jun; 21(6):605-8. PubMed ID: 18282244
    [No Abstract]   [Full Text] [Related]  

  • 47. Mediterranean visceral leishmaniasis in pregnancy.
    Gradoni L; Gaeta GB; Pellizzer G; Maisto A; Scalone A
    Scand J Infect Dis; 1994; 26(5):627-9. PubMed ID: 7855563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
    Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
    J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-transplant lymphoproliferative disorders.
    Singavi AK; Harrington AM; Fenske TS
    Cancer Treat Res; 2015; 165():305-27. PubMed ID: 25655616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EBV and posttransplantation lymphoproliferative disease: what to do?
    Zimmermann H; Trappe RU
    Hematology Am Soc Hematol Educ Program; 2013; 2013():95-102. PubMed ID: 24319169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Solid Mass in the Chest Wall.
    Alagoz S; Yalin SF; Gulcicek S; Ozgur N; Altiparmak MR; Seyahi N
    Prog Transplant; 2016 Dec; 26(4):386-388. PubMed ID: 27555070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of viral infections in immunosuppressed patients].
    Salavert M; Granada R; Díaz A; Zaragoza R
    Med Intensiva; 2011 Mar; 35(2):117-25. PubMed ID: 21324552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Visceral leishmaniasis as an unusual infectious complication in a patient with Crohn's disease treated with infliximab.
    Hernández M; González-Lama Y; Ramos A; Martínez-Ruiz R; Calvo M; Matallana V; Vera MI; Suarez C; Blázquez I; Abreu L
    Gastroenterol Hepatol; 2015; 38(6):411-2. PubMed ID: 25443540
    [No Abstract]   [Full Text] [Related]  

  • 55. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
    Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
    Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Post-transplantation lymphoproliferative disorder in childhood].
    Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
    Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Post-transplant lymphoproliferative disorders following solid-organ transplantation.
    Blaes AH; Morrison VA
    Expert Rev Hematol; 2010 Feb; 3(1):35-44. PubMed ID: 21082932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review.
    Zhu K; Chen J; Chen S
    Hematology; 2005 Oct; 10(5):365-70. PubMed ID: 16273722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management.
    Veroux M; Corona D; Giuffrida G; Cacopardo B; Sinagra N; Tallarita T; Giaquinta A; Zerbo D; Veroux PF
    Transpl Infect Dis; 2010 Oct; 12(5):387-91. PubMed ID: 20534033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.